BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 25/09/2025

FDA Announces Draft Guidance for Expedited Regenerative Medicine Therapies

The FDA is releasing a draft document outlining expedited development and review recommendations for regenerative medicine therapies for serious conditions, which will eventually replace the 2019 guidance.

Source: Federal Register — Food and Drug AdministrationOpen original release →